Reach Us +44-1647-403003
Risk Reduction In Cell Therapy | 5113
ISSN: 2157-7013

Journal of Cell Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Risk reduction in cell therapy

International Conference on Emerging Cell Therapies

Randy Yerden

ScientificTracks Abstracts: J Cell Sci Ther

DOI: 10.4172/2157-7013.S1.002

C ell therapy is a promising but new type of treatment for a wide variety of human afflictions. Learn how cytocentric barrier isolators can substantially reduce risk compared to conventional open cleanrooms in the GMP compliant production of clinical grade cells for cell therapy.
Relevant Topics